Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trialPaul D. Brown, Nadia N. Laack, Jeffrey S. Wefel et al.|Neuro-Oncology|2013Cited by 942
Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001Paul D. Brown, Vinai Gondi, Stephanie L. Pugh et al.|Journal of Clinical Oncology|2020Cited by 827